KALETRA Or LEXIVA With Ritonavir Combined With EPIVIR And Abacavir In Naive Subjects Over 48 Weeks

NCT00085943 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

866

Enrollment

INDUSTRY

Sponsor class

Conditions

HIV Infection
Infection, Human Immunodeficiency Virus

Interventions

DRUG: LEXIVA (GW433908)
DRUG: Ritonavir
DRUG: KALETRA
DRUG: EPIVIR
DRUG: Ziagen
DRUG: Abacavir/Lamivudine
DRUG: Fosamprenavir

Sponsor

GlaxoSmithKline